163 related articles for article (PubMed ID: 20971752)
61. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma.
Galanaud D; Chinot O; Nicoli F; Confort-Gouny S; Le Fur Y; Barrie-Attarian M; Ranjeva JP; Fuentès S; Viout P; Figarella-Branger D; Cozzone PJ
J Neurosurg; 2003 Feb; 98(2):269-76. PubMed ID: 12593610
[TBL] [Abstract][Full Text] [Related]
62. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP
Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287
[TBL] [Abstract][Full Text] [Related]
63. Dynamic 1H-MRS assessment of brain tumors: a novel approach for differential diagnosis of glioma.
Tong T; Yang Z; Chen JW; Zhu J; Yao Z
Oncotarget; 2015 Oct; 6(31):32257-65. PubMed ID: 26337080
[TBL] [Abstract][Full Text] [Related]
64. Multimodal elucidation of choline metabolism in a murine glioma model using magnetic resonance spectroscopy and 11C-choline positron emission tomography.
Wehrl HF; Schwab J; Hasenbach K; Reischl G; Tabatabai G; Quintanilla-Martinez L; Jiru F; Chughtai K; Kiss A; Cay F; Bukala D; Heeren RM; Pichler BJ; Sauter AW
Cancer Res; 2013 Mar; 73(5):1470-80. PubMed ID: 23345160
[TBL] [Abstract][Full Text] [Related]
65. Intraoperative 3-T Magnetic Resonance Spectroscopy for Detection of Proliferative Remnants of Glioma.
Fujita Y; Kohta M; Sasayama T; Tanaka K; Hashiguchi M; Nagashima H; Kyotani K; Nakai T; Ito T; Kohmura E
World Neurosurg; 2020 May; 137():149-157. PubMed ID: 32035198
[TBL] [Abstract][Full Text] [Related]
66. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.
Li FM; Nie Q; Wang RM; Chang SM; Zhao WR; Zhu Q; Liang YK; Yang P; Zhang J; Jia HW; Fang HH
Nucl Med Biol; 2012 Apr; 39(3):437-42. PubMed ID: 22172386
[TBL] [Abstract][Full Text] [Related]
67. Primary and metastatic intraaxial brain tumors: prospective comparison of multivoxel 2D chemical-shift imaging (CSI) proton MR spectroscopy, perfusion MRI, and histopathological findings in a group of 159 patients.
Bendini M; Marton E; Feletti A; Rossi S; Curtolo S; Inches I; Ronzon M; Longatti P; Di Paola F
Acta Neurochir (Wien); 2011 Feb; 153(2):403-12. PubMed ID: 21165751
[TBL] [Abstract][Full Text] [Related]
68. Magnetic resonance spectroscopy detection of high lipid levels in intraaxial tumors without central necrosis: a characteristic of malignant lymphoma.
Yamasaki F; Takayasu T; Nosaka R; Amatya VJ; Doskaliyev A; Akiyama Y; Tominaga A; Takeshima Y; Sugiyama K; Kurisu K
J Neurosurg; 2015 Jun; 122(6):1370-9. PubMed ID: 25748300
[TBL] [Abstract][Full Text] [Related]
69. Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.
Rock JP; Hearshen D; Scarpace L; Croteau D; Gutierrez J; Fisher JL; Rosenblum ML; Mikkelsen T
Neurosurgery; 2002 Oct; 51(4):912-9; discussion 919-20. PubMed ID: 12234397
[TBL] [Abstract][Full Text] [Related]
70. Proton magnetic resonance spectroscopy of cerebral glioma after irradiation.
Ng SH; Ko SF; Chen WC; Tang LM; Chang CN; Wai YY; Wan YL
Chang Gung Med J; 2001 Nov; 24(11):708-16. PubMed ID: 11820651
[TBL] [Abstract][Full Text] [Related]
71. Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions.
Smith EA; Carlos RC; Junck LR; Tsien CI; Elias A; Sundgren PC
AJR Am J Roentgenol; 2009 Feb; 192(2):W45-52. PubMed ID: 19155380
[TBL] [Abstract][Full Text] [Related]
72. The diagnostic challenge of lack of choline level elevation on 1H-MR spectroscopy in grade II-III gliomas.
Bobek-Billewicz B; Heinze S; Majchrzak K; Mazgaj P; Hebda A
Folia Neuropathol; 2024; 62(1):13-20. PubMed ID: 38741433
[TBL] [Abstract][Full Text] [Related]
73. Proton magnetic resonance spectroscopic imaging integrated into image-guided surgery: correlation to standard magnetic resonance imaging and tumor cell density.
Ganslandt O; Stadlbauer A; Fahlbusch R; Kamada K; Buslei R; Blumcke I; Moser E; Nimsky C
Neurosurgery; 2005 Apr; 56(2 Suppl):291-8; discussion 291-8. PubMed ID: 15794826
[TBL] [Abstract][Full Text] [Related]
74. Metabolism and regional cerebral blood volume in autoimmune inflammatory demyelinating lesions mimicking malignant gliomas.
Blasel S; Pfeilschifter W; Jansen V; Mueller K; Zanella F; Hattingen E
J Neurol; 2011 Jan; 258(1):113-22. PubMed ID: 20803026
[TBL] [Abstract][Full Text] [Related]
75. Combination of Magnetic Resonance Spectroscopy and ¹¹C-Methionine Positron Emission Tomography for the Accurate Diagnosis of Non-Enhancing Supratentorial Glioma.
Kudulaiti N; Qiu T; Lu J; Zhang H; Zhang Z; Guan Y; Zhuang D; Wu J
Korean J Radiol; 2019 Jun; 20(6):967-975. PubMed ID: 31132822
[TBL] [Abstract][Full Text] [Related]
76. An MRS- and PET-guided biopsy tool for intraoperative neuronavigational systems.
Grech-Sollars M; Vaqas B; Thompson G; Barwick T; Honeyfield L; O'Neill K; Waldman AD
J Neurosurg; 2017 Oct; 127(4):812-818. PubMed ID: 27834593
[TBL] [Abstract][Full Text] [Related]
77. Gliomatosis cerebri, imaging findings of 12 cases.
Desclée P; Rommel D; Hernalsteen D; Godfraind C; de Coene B; Cosnard G
J Neuroradiol; 2010 Jul; 37(3):148-58. PubMed ID: 20334921
[TBL] [Abstract][Full Text] [Related]
78. Pediatric low-grade gliomas: prognosis with proton magnetic resonance spectroscopic imaging.
Lazareff JA; Bockhorst KH; Curran J; Olmstead C; Alger JR
Neurosurgery; 1998 Oct; 43(4):809-17; discussion 817-8. PubMed ID: 9766308
[TBL] [Abstract][Full Text] [Related]
79. Clinicopathological examination of glioma by proton magnetic resonance spectroscopy background.
Izumiyama H; Abe T; Tanioka D; Fukuda A; Kunii N
Brain Tumor Pathol; 2004; 21(1):39-46. PubMed ID: 15696968
[TBL] [Abstract][Full Text] [Related]
80. Molecular and metabolic pattern classification for detection of brain glioma progression.
Imani F; Boada FE; Lieberman FS; Davis DK; Mountz JM
Eur J Radiol; 2014 Feb; 83(2):e100-5. PubMed ID: 24321226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
